Industry reports
Editor highlights

Publication dates

All regions

Colorectal Cancer Research Reports, April 2014

You might be interested in: cancer, medical equipment, breast cancer, more »


 

1-20 of about 8 700 reports for Colorectal Cancer
Colorectal Cancer Drug Pathway Analyzer 2014

Colorectal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... To affect more than 250 specific intracellular signaling pathways for the treatment of colorectal cancer. The rational for this plethora of treatment strategies is based on our increasing understanding ...

Analytical Tool - Colorectal Cancer

Analytical Tool - Colorectal Cancer

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

... Recent advances in the field of colorectal cancer drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research ...

Colorectal Cancer Drug Pipeline Update 2014

Colorectal Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

... And the accumulated number of ceased drugs over the last years amount to another 180 drugs. colorectal cancer drug pipeline update lists all drugs and gives you a progress analysis on each one of them. Identified drugs ...

immatics biotechnologies GmbH - Strategic SWOT Analysis Review

immatics biotechnologies GmbH - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • March 2014
  • by Global Data

... Opportunity - market outlook:colorectal cancer and renal cancer 16immatics biotechnologies gmbh - threats 16threat - government regulations 16threat - competition and technological change 17 ...

Colorectal Cancer Partnering 2009-2014

Colorectal Cancer Partnering 2009-2014

  • $ 995
  • Industry report
  • March 2014
  • by Currentpartnering

... This data driven report contains over 150 links to online copies of actual colorectal cancer deals and contract documents as submitted to the securities exchange commission by companies and their partners ...

Metastatic Colorectal Cancer - Pipeline Review, H1 2014

Metastatic Colorectal Cancer - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

... Projects- coverage of the metastatic colorectal cancer pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline products ...

Cancer Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cancer Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... Immunology and cancer immunology research. It conducts clinical trials for several cancer types such as breast cancer, colorectal cancer, lung cancer, melanoma and prostate cancer. Cri's cancer immunotherapy ...

Onyx Pharmaceuticals, Inc. (ONXX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Onyx Pharmaceuticals, Inc. (ONXX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Kyprolis is used for the treatment of patients with multiple myeloma. Stivarga is used for the treatment of patients with metastatic colorectal cancer. Its under developed product include onx 0912 ...

H. Lee Moffitt Cancer Center & Research Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

H. Lee Moffitt Cancer Center & Research Institute, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

... Cancer, brain cancer, cervical cancer, colorectal cancer, endometrial cancer, esophageal cancer, gallbladder cancer, gastrointestinal carcinoid tumor, leukemia, liver cancer and lung cancer. The institute ...

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • February 2014
  • by Global Data

... Depletion and recovery technology for serum or plasma and other biological fluids. The company offers products for the treatment of colorectal cancer and prostate cancer. It holds for vascular permeability ...


» Read our Company Profiles

1 Companies for Colorectal Cancer

Merck KGaA

Germany

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.